Endurant Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Endurant Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-114,980	Closed	-$2.82M	–	100
2016 Q3	$2.82M	Buy	114,980 +42,600	+59%	+$1.06M	1.04%	33
2016 Q2	$1.73M	Sell	72,380 -192,800	-73%	-$4.42M	0.58%	46
2016 Q1	$6.21M	Buy	265,180 +154,000	+139%	+$3.66M	2.01%	23
2015 Q4	$3.36M	Buy	111,180 +17,080	+18%	+$552K	1.12%	32
2015 Q3	$3.74M	Buy	+94,100	New	+$5.84M	1.25%	29
2015 Q2	–	Sell	-10,100	Closed	-$552K	–	111
2015 Q1	$552K	Buy	+10,100	New	+$481K	0.18%	81

Other funds holding AMAG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Endurant Capital Management's AMAG Position: Q4 2016 in Review

Endurant Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2016, closing a stake of 114,980 shares — an estimated $2.82M sold.

Endurant Capital Management first reported a position in AMAG in Q1 2015 and held it in 6 quarters. The position peaked at $6.21M in Q1 2016. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

Endurant Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Endurant Capital Management sold 114,980 AMAG Pharmaceuticals shares in Q4 2016, an estimated $2.82M.
Endurant Capital Management first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Endurant Capital Management's AMAG Pharmaceuticals position peaked at $6.21M in Q1 2016.
206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on Endurant Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.